Document is current
Any future updates will be listed below
-
Authors
Li, Jiyun
Tian, Ruoxi
Liu, Hengchang
Chen, Haipeng
Zheng, Zhaoxu
-
Funding
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2021A23, LC2021A23, LC2021A23, LC2021A23, LC2021A23)
Beijing Science and Technology Medical Development Foundation (KC2022-JF-0090-01, KC2022-JF-0090-01, KC2022-JF-0090-01, KC2022-JF-0090-01, KC2022-JF-0090-01)
Wu Jieping Medical Foundation (number:320.6750.2022-06-8, number:320.6750.2022-06-8, number:320.6750.2022-06-8, number:320.6750.2022-06-8, number:320.6750.2022-06-8)
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 9 January 2025
First Online: 23 January 2025
Declarations
:
: This study was approved by the Institutional Review Board Committee of the Cancer Hospital, Chinese Academy of Medical Science, and Peking Union Medical College, Beijing, China. All patients enrolled in this study provided written informed consent.
: Not applicable.
: The authors declare no competing interests.
